ROI Influencers: Health Care 2023
Dr. Haro Hartounian
CEO
BioCentriq
Hartounian heads cell and gene therapy contract development and manufacturing organization that was launched at NJII in Newark and recently sold to Green Cross Holdings, a Korean company, for $73 million.